TROPONIN ELEVATION DURING PACEMAKER IMPLANTATION IS DEPENDENT ON LEAD POSITION AND IS NOT PREDICTIVE OF ACUTE PACING PARAMETERS AT IMPLANT

Methods In consecutive patients (normal LV, renal function and no significant valvular disease) referred for PMI using active fixation leads, troponin I levels (TI) were determined at baseline, and 2-6, 6-12 and 12-18 hours post PMI using a commercially available assay (Siemens Vista high sensitivit...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.856-856
Main Authors: Salacata, Abraham S, Kaczmierzak, Christopher, Rosenberg, Brenda, Thompson, Amanda, Spade, Cathy
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods In consecutive patients (normal LV, renal function and no significant valvular disease) referred for PMI using active fixation leads, troponin I levels (TI) were determined at baseline, and 2-6, 6-12 and 12-18 hours post PMI using a commercially available assay (Siemens Vista high sensitivity assay, normal range
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)30857-9